| human | Q5 |
| P496 | ORCID iD | 0000-0002-5518-9360 |
| P4789 | Who's Who UK ID | U290650 |
| P512 | academic degree | Doctor of Philosophy | Q752297 |
| Doctor of Medicine | Q913404 | ||
| P27 | country of citizenship | United Kingdom | Q145 |
| P108 | employer | University of Cambridge | Q35794 |
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | university teacher | Q1622272 |
| radiologist | Q18245236 | ||
| P21 | sex or gender | male | Q6581097 |
| Q113320702 | 3D deformable registration of longitudinal abdominopelvic CT images using unsupervised deep learning |
| Q48132312 | A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome |
| Q40412717 | Abdominal wall endometriosis: differentiation from other masses using CT features |
| Q58283638 | Added Value of Diffusion-Weighted Imaging in Endometrial Cancer |
| Q83422597 | Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma |
| Q37802974 | Adnexal masses: characterization and imaging strategies |
| Q53175270 | Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. |
| Q53258272 | Advances in magnetic resonance imaging of endometrial cancer. |
| Q51805184 | Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development. |
| Q93361618 | Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer |
| Q35683375 | Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study |
| Q48079143 | Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer |
| Q36306100 | Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images |
| Q47669653 | Background, current role, and potential applications of radiogenomics. |
| Q35461505 | Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer |
| Q52681603 | CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. |
| Q39143177 | Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy |
| Q38207262 | Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer |
| Q105968543 | Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans |
| Q37204265 | Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer |
| Q89945283 | Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors |
| Q99352037 | Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer |
| Q37802975 | Congenital and Acquired Conditions of the Vulva and Vagina on Magnetic Resonance Imaging: A Pictorial Review |
| Q103776866 | Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma |
| Q40808567 | Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists |
| Q37011743 | Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus |
| Q40439766 | Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis |
| Q92153808 | Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer |
| Q90107776 | Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer? |
| Q95448784 | Dr Freeman and colleagues respond |
| Q36695654 | Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. |
| Q39885166 | Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease. |
| Q37788612 | ESUR guidelines: ovarian cancer staging and follow-up |
| Q58283606 | Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology |
| Q33620485 | Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade |
| Q36351007 | Endorectal MR imaging before salvage prostatectomy: tumor localization and staging |
| Q36372949 | Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis |
| Q50056757 | Erratum to: Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management |
| Q115487904 | Error Reduction in Parameter Estimation from the Segmented Intravoxel Incoherent Motion Bi-exponential Model |
| Q36088325 | Evaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance Imaging |
| Q58613245 | Evaluation of Nonenhancing Tumor Fraction Assessed by Dynamic Contrast-Enhanced MRI Subtraction as a Predictor of Decrease in Tumor Volume in Response to Chemoradiotherapy in Advanced Cervical Cancer |
| Q39678160 | Evaluation of carotid stenosis with axial high-resolution black-blood MR imaging |
| Q37960457 | Evaluation of depth of myometrial invasion and overall staging in endometrial cancer: comparison of diffusion-weighted and dynamic contrast-enhanced MR imaging. |
| Q36229421 | Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study |
| Q83212388 | FIGO staging system for endometrial cancer: added benefits of MR imaging |
| Q89748868 | Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T1 and T2 Mapping in a PET/MR Setting |
| Q38681393 | Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management. |
| Q39408543 | From Staging to Prognostication: Achievements and Challenges of MR Imaging in the Assessment of Endometrial Cancer |
| Q37272279 | Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine |
| Q41110614 | Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. |
| Q41571576 | Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient. |
| Q39382941 | High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes |
| Q64068001 | How clinical imaging can assess cancer biology |
| Q98504311 | Hyperpolarized 13C MRI of Tumor Metabolism Demonstrates Early Metabolic Response to Neoadjuvant Chemotherapy in Breast Cancer |
| Q53398907 | Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique? |
| Q33886628 | Imaging Features of Uncommon Gynecologic Cancers |
| Q92823311 | Imaging breast cancer using hyperpolarized carbon-13 MRI |
| Q30975500 | Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer |
| Q102207556 | Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma |
| Q91613407 | Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis |
| Q98506881 | Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer |
| Q51251440 | Interactive magnetic resonance cholangiography (MRC) with adaptive averaging. |
| Q34714653 | Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes |
| Q36794300 | Is It Time to Centralize Ovarian Cancer Care in the United States? |
| Q38877792 | Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide? |
| Q37222002 | Lossy 3D JPEG2000 compression of abdominal CT images in patients with acute abdominal complaints: effect of compression ratio on diagnostic confidence and accuracy. |
| Q31108842 | METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer. |
| Q52669254 | MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy. |
| Q89950603 | MRI of Bladder Cancer: Local and Nodal Staging |
| Q91707153 | MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space-based Approach |
| Q36827551 | MRI of malignant neoplasms of the uterine corpus and cervix. |
| Q38077164 | MRI of ovarian masses |
| Q102071180 | MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance |
| Q37802981 | Magnetic Resonance Imaging for the Evaluation of Acute Abdominal Pain in Pregnancy |
| Q100694348 | Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T |
| Q36395118 | Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer |
| Q38164525 | Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration |
| Q53424566 | Medical image. A prepubescent mass. Swyer syndrome with a bilateral dysgerminoma. |
| Q33488910 | Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T. |
| Q33620520 | Molecular Imaging of Prostate Cancer |
| Q38360681 | Molecular imaging of prostate cancer: translating molecular biology approaches into the clinical realm |
| Q62050250 | Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer |
| Q51552952 | Nonovarian cystic lesions of the pelvis. |
| Q102149084 | Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pre-treatment Prostate MRI Findings |
| Q37777633 | Ovarian cancer: the role of functional imaging as an end point in clinical trials |
| Q38052052 | Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. |
| Q38076380 | Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique |
| Q51533819 | Pelvic Imaging Following Chemotherapy and Radiation Therapy for Gynecologic Malignancies |
| Q57392752 | Pelvis |
| Q37179980 | Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion |
| Q53152354 | Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate- or high-risk prostate cancer. |
| Q37136039 | Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus. |
| Q53058454 | Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. |
| Q33849173 | Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla |
| Q63383744 | Prostate cancer: performance characteristics of combined T2W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion |
| Q99352036 | Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer |
| Q36412660 | Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group |
| Q37802978 | Radiological Staging of Ovarian Carcinoma |
| Q89724461 | Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma-a systematic review and meta-analysis |
| Q41110412 | Ratio of Tumor to Normal Prostate Tissue Apparent Diffusion Coefficient as a Method for Quantifying DWI of the Prostate |
| Q53136945 | Rationale for Modernising Imaging in Advanced Prostate Cancer. |
| Q37053323 | Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival |
| Q40377680 | Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement |
| Q90840685 | Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis |
| Q37495153 | Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volume. |
| Q95787530 | Response |
| Q112613450 | Robustness of radiomic features in CT images with different slice thickness, comparing liver tumour and muscle |
| Q28088565 | Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies |
| Q37846024 | Role of MRI in intracavitary brachytherapy for cervical cancer: what the radiologist needs to know |
| Q38222519 | Role of imaging in the pretreatment evaluation of common gynecological cancers |
| Q43725295 | Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration |
| Q38614611 | Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care |
| Q53385495 | Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. |
| Q64229928 | Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury |
| Q64100548 | Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer |
| Q28649475 | Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis |
| Q55039219 | Structured reporting of pelvic MRI leads to better treatment planning of uterine leiomyomas. |
| Q33747375 | T1-weighted fat-suppressed imaging of the pelvis with a dual-echo Dixon technique: initial clinical experience. |
| Q96835782 | T2-Hypointense Adnexal Lesions: An Imaging Algorithm |
| Q51344715 | T2-hypointense adnexal lesions: an imaging algorithm. |
| Q36991978 | The Wheel of the Mesentery: Imaging Spectrum of Primary and Secondary Mesenteric Neoplasms--How Can Radiologists Help Plan Treatment?: Resident and Fellow Education Feature |
| Q56780081 | The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study |
| Q38083654 | The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: what the radiologist needs to know. |
| Q92874067 | The effect of capped biparametric magnetic resonance imaging slots on weekly prostate cancer imaging workload |
| Q96615767 | The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy |
| Q37976257 | The emerging role of diffusion-weighted MRI in prostate cancer management |
| Q33762501 | The expanding landscape of diffusion-weighted MRI in prostate cancer |
| Q38930394 | The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer |
| Q38052053 | The revised FIGO staging system for uterine malignancies: implications for MR imaging |
| Q37784564 | The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis |
| Q30584396 | The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration |
| Q84485121 | The value of postoperative/preadjuvant chemotherapy computed tomography in the management of patients with ovarian cancer |
| Q35663648 | Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery |
| Q98507555 | Three-Dimensional Printed Molds for Image-Guided Surgical Biopsies: An Open Source Computational Platform |
| Q95283828 | Tissue-specific and interpretable sub-segmentation of whole tumour burden on CT images by unsupervised fuzzy clustering |
| Q36434291 | Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging |
| Q125820430 | Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer |
| Q46976947 | Unexpected changes in clinical diagnosis: early abdomino-pelvic computed tomography compared with clinical evaluation. |
| Q96127196 | Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy |
| Q38580628 | Updates in advanced diffusion-weighted magnetic resonance imaging techniques in the evaluation of prostate cancer |
| Q53300927 | Visceral abdominal obesity--is there an increased prevalence in men presenting with testicular teratoma? |
Search more.